This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Visterra, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Tyree J Koch: Innovator in Antibody Molecule-Drug Conjugates
Introduction
Tyree J Koch is a prominent inventor based in Seattle, WA. He has made significant contributions to the field of biotechnology, particularly in the development of antibody molecule-drug conjugates. His innovative work aims to enhance the treatment and diagnosis of bacterial infections.
Latest Patents
Tyree J Koch holds 1 patent for his invention titled "Antibody molecule-drug conjugates and uses thereof." This patent discloses antibody molecule-drug conjugates (ADCs) that specifically bind to lipopolysaccharides (LPS). These conjugates can be utilized to treat, prevent, and diagnose bacterial infections and related disorders.
Career Highlights
Tyree J Koch is currently employed at Visterra, Inc., where he continues to advance his research and development efforts. His work at Visterra has positioned him as a key player in the biotechnology sector, focusing on innovative solutions for complex medical challenges.
Collaborations
Tyree has collaborated with notable colleagues, including Karthik Viswanathan and Kenneth Douglas Johnson. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in their field.
Conclusion
Tyree J Koch's contributions to the development of antibody molecule-drug conjugates represent a significant advancement in the fight against bacterial infections. His innovative spirit and dedication to research continue to inspire progress in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile